Biotech Values

[drbio45]

I believe this puts dor in play

Sigma tau has an option until march 1st for the european rights

dor can't negotiate with anyone else until that lapses. that does not stop other offers and it also doesn't mean they need to accept sigma tau's offer

Anormed was trading at 4 dollars until genz offered 8.55 a share

millenium then offered 12 and finally genz bought them for 13.50 or 580 million.

dor won't go for anywhere near that amount but I don't think a dollar a share is out of the question, and from a better company than ctic